What are the semaglutide side effects
Diarrhea was reported in 34.7% and 33.1%, constipation in 21.8% and 25.0%, and vomiting in 20.4% and 20.9%, respectively
Key comparisons between the Retatrutide pen and vial: Ease of use: Pens come prefilled or pre-mixed, allowing for quick, once-weekly self-injection under supervision
Sources: - Lilly's next-gen drug tops Zepbound on weight loss in late-stage osteoarthritis trial (Published: 2025-12-11) - - American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease - 2025 Update - PubMed (Published: 2025-01-01) - - Introduction and methodology: Standards of Care in Overweight and Obesity2025 | BMJ Open Diabetes Research & Care (Published: 2025-05-23) - #ObesityMedicine #WeightLoss #Retatrutide #TripleAgonist #GLP1 #ChronicDisease #HealthcareInnovation #Pharma #CardiovascularHealth #ObesityTreatment To view or add a comment, sign in Obesity, Metabolic Syndrome, and Osteoarthritis Require Integrative Understanding and Management by Mocanu, V., et al
For more information: Maya Brownstein [email protected] ### Harvard T.H